Gene expression changes after ionizing radiation in endothelial cells derived from human endometrial cancer-preliminary outcomes

Archives of Gynecology and Obstetrics

Volumn 289, Issue 6, 2014, Pages 1315-1323

  Liu, Ting ^a,b   Du, Xuelian ^a   Sheng, Xiugui ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b LINYI CANCER HOSPITAL   (China)

Author keywords

Anti angiogenesis; Cancer derived endothelial cells; Endometrial cancer; Gene microarray; Radiosensitivity

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 15; MYXOVIRUS RESISTANCE PROTEIN; PLATELET DERIVED GROWTH FACTOR C; THROMBOSPONDIN 1;

ADULT; AKR1B1 GENE; APOPTOSIS; ARTICLE; BBC3 GENE; CAMP GENE; CANCER GROWTH; CCL18 GENE; CCNE1 GENE; CDKN1A GENE; CELL ADHESION; CELL CYCLE REGULATION; CELL STRESS; CHEMOKINESIS; CLEC5A GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL1 GENE; CXCL12 GENE; DDB2 GENE; DNA REPAIR; DNA SYNTHESIS; ECGF1 GENE; ENDOMETRIUM CANCER; ENDOTHELIUM CELL; EPHB2 GENE; FAM25 HUMAN GENE; FEMALE; FILIP1L GENE; GDF15 GENE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IL18 GENE; IONIZING RADIATION; ISG15 GENE; MICROARRAY ANALYSIS; MIDDLE AGED; MMD GENE; MMP1 GENE; MMP9 GENE; MRPS6 GENE; MX1 GENE; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; ONCOGENE; PDGFC GENE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THBS1 GENE; X RAY;

ADULT; CARCINOMA; CELLS, CULTURED; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84905185126     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3136-x     Document Type: Article

References (39)

1. Nout RA, Smit VT, Putter H et al (2010) Aginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816-823
2. Shaeffer DT, Randall ME (2005) Adjuvant radiotherapy in endometrial carcinoma. Oncologist 10:623-631 (Pubitemid 41429125)
3. Peltenburg LT (2000) Radiosensitivity of tumor cells. Oncogenes and apoptosis. Q J Nucl Med 44:355-364
4. Awasthi S, Singhal SS, Yadav S et al (2005) RLIP76 is a major determinant of radiation sensitivity. Cancer Res 65:6022-6028 (Pubitemid 40994385)
5. Du XL, Jiang T, Wen ZQ, Li QS, Gao R, Wang F (2009) Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities. Oncol Rep 21:625-634
6. Giatromanolaki A, Sivridis E, Koukourakis MI et al (1999) Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? Oncol Res 11:205-212
7. Kamat AA, Merritt WM, Coffey D et al (2007) Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res 13:7487-7495
8. Koyanagi T, Saga Y, Takahashi Y et al (2013) Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells. Oncol Lett 5:1058-1062
9. Gordon LK, Kiyohara M, Fu M et al (2013) EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene 32:5369-5376
10. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
11. Carmeliet P, Ain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
12. Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8:89-91 (Pubitemid 41132735)
13. Folkman J, Amphausen K (2001) Cancer. What does radiotherapy do to endothelial cells? Science 293:227-228 (Pubitemid 32694723)
14. Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5:429-441 (Pubitemid 38610245)
15. Garcia-Barros M, Paris F, Cordon-Cardo C et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159 (Pubitemid 36583102)
16. Du XL, Jiang T, Zhao WB et al (2008) Gene alterations in tumor-associated endothelial cells from endometrial cancer. Int J Mol Med 22:619-632
17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408 (Pubitemid 34164012)
18. Raman D, Baugher PJ, Thu YM, Ichmond S (2007) Role of chemokines in tumor growth. Cancer Lett 256:137-165 (Pubitemid 47418345)
19. Wolff HA, Rolke D, Rave-Fränk M et al (2011) Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines. Radiat Environ Biophys 50:145-154
20. Chang CC, Lerman OZ, Thanik VD et al (2009) Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells. Cytokine 48:295-302
21. Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292:C987-C995 (Pubitemid 46440396)
22. Kioi M, Vogel H, Schultz G et al (2010) Inhibition of vasculo-genesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120:694-705
23. Taraboletti G, Roberts D, Liotta LA, Giavazzi R (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111:765-772
24. Tolsma SS, Volpert OV, Good DJ et al (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511 (Pubitemid 23210475)
25. Rofstad EK, Henriksen K, Galappathi K, Mathiesen B (2003) Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts. Cancer Res 63:4055-4061 (Pubitemid 36917927)
26. Rofstad EK, Galappathi K, Mathiesen B (2004) Thrombospondin-1 treatment prevents growth of dormant lung micrometastases after surgical resection and curative radiation therapy of the primary tumor in human melanoma xenografts. Int J Radiat Oncol Biol Phys 58:493-499 (Pubitemid 38142476)
27. Maxhimer JB, Soto-Pantoja DR, Ridnour LA et al (2009) Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med 1:3ra7
28. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9:182-194
29. Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13:193-205
30. Jadhav U, Mohanam S (2006) Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells. Int J Oncol 29:1525-1531
31. Vorotnikova E, Tries M, Braunhut S (2004) Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells. Radiat Res 161:174-184 (Pubitemid 38129811)
32. Zhang G, Wang Y, Zhang Y et al (2012) Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med 12:163-176
33. Kaliski A, Maggiorella L, Cengel KA et al (2005) Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 4:1717-1728 (Pubitemid 41685306)
34. Kim R, Murakami S, Toge T (2003) Effects of introduction of dThdPase cDNA on sensitivity to 5′-deoxy-5-fluorouridine and tumor angiogenesis. Int J Oncol 22:835-841
35. Mazurek A, Kuc P, Terlikowski S, Laudanski T (2006) Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer. Neoplasma 53:242-246 (Pubitemid 43844384)
36. Koukourakis MI, Giatromanolaki A, Fountzilas G et al (2000) Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 6:381-389 (Pubitemid 30111454)
37. Miszczak-Zaborska E, Kubiak R, Bieńkiewicz A, Bartkowiak J (2008) The cytosol activity of thymidine phosphorylase in endometrial cancer. J Exp Clin Cancer Res 27:64
38. Miyatani T, Kurita N, Utsunomiya T et al (2012) Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer. Cancer Lett 318:199-205
39. Chang JT, Chan SH, Lin CY et al (2007) Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 6:2271-2279 (Pubitemid 47294755)